Skip to content
value.today

Aurobindo Pharma Limited vs Cipla Limited

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • Cipla Limited is the larger company by market value: $12.3 B against $11.2 B for Aurobindo Pharma Limited, 1.1 times as much (market caps of Nov 20, 2026).
  • Aurobindo Pharma Limited had more revenue: $3.6 B against $3.0 B for Cipla Limited, both in the year to March 2026.
  • Cipla Limited earned more: net income of $419 M against $378 M for Aurobindo Pharma Limited.
  • Cipla Limited keeps more of each dollar of sales: a net margin of 14.0% against 10.5% for Aurobindo Pharma Limited.
  • Cipla Limited employs more people: 23,000 against 15,690 at Aurobindo Pharma Limited. Each employee brings in about $229,751 of revenue at Aurobindo Pharma Limited and $130,097 at Cipla Limited.
  • On price to earnings, Aurobindo Pharma Limited trades at 29.5× and Cipla Limited at 29.4×: investors pay more for each dollar of Aurobindo Pharma Limited's profit.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

0741472212952020202120222023202420252026Aurobindo Pharma Limited 295Cipla Limited 231

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureAurobindo Pharma Limited
AUROPHARMA.NS · #2,011 in the world
Cipla Limited
CIPLA.BO · #1,863 in the world
Profile
Country🇮🇳 India🇮🇳 India
SectorHealthcareHealthcare
IndustryPharmaceuticalPharmaceutical
Founded19861935
Size
Market cap$11.2 B$12.3 B
Revenue$3.6 B$3.0 B
Net income$378 M$419 M▲ best
Employees15,69023,000
Valuation
P/E ratio29.5×29.4×
Price to sales3.1×4.1×
Price to book2.7×3.3×
Altman Z-score zone——
Data as ofMarket cap Nov 2026Market cap Nov 2026

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, Aurobindo Pharma Limited or Cipla Limited?

Cipla Limited is the larger company by market value: $12.3 B against $11.2 B for Aurobindo Pharma Limited, 1.1 times as much (market caps of Nov 20, 2026).

Which makes more money, Aurobindo Pharma Limited or Cipla Limited?

Aurobindo Pharma Limited had more revenue: $3.6 B against $3.0 B for Cipla Limited, both in the year to March 2026. Cipla Limited earned more: net income of $419 M against $378 M for Aurobindo Pharma Limited.

Which is more profitable, Aurobindo Pharma Limited or Cipla Limited?

Cipla Limited keeps more of each dollar of sales: a net margin of 14.0% against 10.5% for Aurobindo Pharma Limited.

Which has more employees, Aurobindo Pharma Limited or Cipla Limited?

Cipla Limited employs more people: 23,000 against 15,690 at Aurobindo Pharma Limited. Each employee brings in about $229,751 of revenue at Aurobindo Pharma Limited and $130,097 at Cipla Limited.

Is Aurobindo Pharma Limited cheaper than Cipla Limited?

On price to earnings, Aurobindo Pharma Limited trades at 29.5× and Cipla Limited at 29.4×: investors pay more for each dollar of Aurobindo Pharma Limited's profit. A lower multiple is not by itself a better buy: it also reflects expected growth, risk and accounting.

Sources#

Every figure on this page comes from these, with the date shown next to it.